HedgeChatter

  • Home /
  • Tag Archives

ZGNX

Preliminary Findings From Rheumatoid Arthritis Patient Survey Reveal Strong Interest in Needle-Free Self-Injection

[at noodls] – Survey Finds RA Patients’ Willingness to Accept Prescriptions for Self-Injected Medication Substantially Increases if Needle-Free Option Available COLUMBUS, Ohio and SAN DIEGO, Nov. 13, 2012 (GLOBE NEWSWIRE) … moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboard […]

November 13, 2012 Bystocknews , Comments Off on Preliminary Findings From Rheumatoid Arthritis Patient Survey Reveal Strong Interest in Needle-Free Self-Injection read more

Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain

[at noodls] – SAN DIEGO, Nov. 8, 2012 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, … moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboard […]

November 8, 2012 Bystocknews , Comments Off on Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain read more

PropThink: Pfizer Spooks Durect Investors, Creates Opportunity

[ACN Newswire] – By Jason Napodano, CFAOn November 1, 2012, Pfizer (NYSE:PFE) held a conference call ( webcast link ) to discuss its third quarter earnings and financial outlook with investors. In the past, Pfizer’s conference … moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboard […]

November 6, 2012 Bystocknews , Comments Off on PropThink: Pfizer Spooks Durect Investors, Creates Opportunity read more

Zogenix to Present New Case Study Highlighting Successful Repositioning of Injectable Sumatriptan for Migraine With a Novel Needle-Free Delivery Technology

[at noodls] – Presentation at the 2nd Annual Drug Repositioning & Indications Discovery Conference to Demonstrate Increased Adoption of a Standard Therapy Used With DosePro(R) Technology SAN DIEGO, Oct. 23, 2012 (GLOBE … moreView todays social media effects on ZGNXView the latest stocks trending across Twitter. Click to view dashboard […]

October 23, 2012 Bystocknews , Comments Off on Zogenix to Present New Case Study Highlighting Successful Repositioning of Injectable Sumatriptan for Migraine With a Novel Needle-Free Delivery Technology read more